Structual Heart Diseases: Course Objectives

Transcatheter Aortic Valve Implantation (TAVI) was introduced in Japan in October, 2013, and MitraClip has been available since April, 2018. Catheter intervention in the field of Structural Heart Diseases (SHD) is rapidly evolving and it is highly expected to keep developing in the future. The SHD Live Case Transmission for this year is scheduled to cover the whole procedures of SHD therapy in the morning of Friday, October 26. We would like to hold interesting sessions in order to attract as many participants as possible. We are looking forward to seeing many physicians at the venue.

Shigeru Saito
CCT Representative Structural Heart Diseases Course Director